phenolsulfonphthalein has been researched along with betadex in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Glabe, CG; Kayed, R; Milton, S; Necula, M | 1 |
Iwaki, M; Ogiso, T; Tanino, T | 1 |
Iwaki, M; Kakehi, K; Ogiso, T; Tanino, T; Yamaguchi, T | 1 |
3 other study(ies) available for phenolsulfonphthalein and betadex
Article | Year |
---|---|
Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct.
Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Humans; Plaque, Amyloid; Protein Structure, Quaternary; Thermodynamics | 2007 |
Effect of sugar-modified beta-cyclodextrins on dissolution and absorption characteristics of phenytoin.
Topics: Animals; beta-Cyclodextrins; Cyclodextrins; Drug Interactions; Glucose; Intestinal Mucosa; Intestines; Male; Maltose; Membrane Proteins; Permeability; Phenolsulfonphthalein; Phenytoin; Phospholipids; Powders; Rats; Rats, Wistar; Solubility; X-Ray Diffraction | 1999 |
Release characteristics of endogenous constituents by exposure of small intestine to modified beta-cyclodextrins.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Carcinogens; Cholesterol; Cyclodextrins; Indicators and Reagents; Intestinal Absorption; Intestine, Small; Lipid Metabolism; Male; Phenolsulfonphthalein; Rats; Rats, Wistar | 1999 |